| Rank | Symbol | Company | Insider's Name | Role | Market Cap | Avg. Return | ||
|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics Inc | Tighe Reardon | Acting Chief Financial Officer | $1.22B | 751.96% | |||
| SEZL | Sezzle Inc. | Charles Youakim | Executive Chairman and CEO | $3.98B | 585.09% | |||
| RLMD | Relmada Therapeutics Inc | Paul Edward Kelly | Chief Operating Officer | $445.78M | 527.39% | |||
| MNPR | Monopar Therapeutics Inc | Andrew Cittadine | Chief Operating Officer | $766.24M | 525.00% | |||
| ROOT | Root Inc - Class A | Mahtiyar Bonakdarpour | Chief Technology Officer | $766.20M | 514.12% | |||
| AGL | Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | $1.52B | 480.13% |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
